Ana Cristina Pannain L Kaufman, Andre Reynaldo Santos Périssé, Cristina Barroso Hofer
{"title":"[Access of children with congenital Zika virus syndrome to public policies].","authors":"Ana Cristina Pannain L Kaufman, Andre Reynaldo Santos Périssé, Cristina Barroso Hofer","doi":"10.1590/0102-311XPT014624","DOIUrl":null,"url":null,"abstract":"<p><p>Congenital Zika syndrome (CZS) is responsible for several malformations, including microcephaly. This study aimed to describe children's access to social public policies: lifetime benefit (E60) created in the face of the Zika virus public health emergency (Espin-ZIKV) or Continuous Cash Benefit/Type 87 (BPC/E87). Thus, this study compares the children's access before and after Espin-ZIKV. This was a cross-sectional study, with data extraction and description from the Brazilian Information System on Live Births (SINASC), the Registry of Public Health Events-Microcephaly (Resp-Microcephaly), and the Unified System for Benefits Information (SUIBE), from 2013 to 2021. We describe the E60 that were still active at the time of SUIBE data extraction in May, 2023. We compared the granting of BPC/E87 for microcephaly in 2013 and 2021 (before and after Espin-ZIKV). Of the 20,000,859 live births from 2015-2021, 20,464 suspected cases of CZS were reported in Resp-Microcephaly; 20% of affected patients received some social benefit: 705 received E60 and 3,822 received BPC/E87. The national average of BPC/E87 granted in 2013 for microcephaly was eight for every 100,000 live births (before Espin-ZIKV), while in 2021 it was five BPC/E87 for every 100,000 live births (after Espin-ZIKV) (p < 0.01). We observed 689 children with active E60 (from 3 to 8 years of age), in May, 2023. The study showed low social protection for children with suspected CZS. However, of those who benefited from the E60, 98% had active benefits in 2023, demonstrating the important survival of the benefited children. A reduction in the mean number of BPC/E87 grants for microcephaly without specified cause was observed after Espin-ZIKV.</p>","PeriodicalId":9398,"journal":{"name":"Cadernos de saude publica","volume":"40 12","pages":"e00014624"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cadernos de saude publica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/0102-311XPT014624","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Congenital Zika syndrome (CZS) is responsible for several malformations, including microcephaly. This study aimed to describe children's access to social public policies: lifetime benefit (E60) created in the face of the Zika virus public health emergency (Espin-ZIKV) or Continuous Cash Benefit/Type 87 (BPC/E87). Thus, this study compares the children's access before and after Espin-ZIKV. This was a cross-sectional study, with data extraction and description from the Brazilian Information System on Live Births (SINASC), the Registry of Public Health Events-Microcephaly (Resp-Microcephaly), and the Unified System for Benefits Information (SUIBE), from 2013 to 2021. We describe the E60 that were still active at the time of SUIBE data extraction in May, 2023. We compared the granting of BPC/E87 for microcephaly in 2013 and 2021 (before and after Espin-ZIKV). Of the 20,000,859 live births from 2015-2021, 20,464 suspected cases of CZS were reported in Resp-Microcephaly; 20% of affected patients received some social benefit: 705 received E60 and 3,822 received BPC/E87. The national average of BPC/E87 granted in 2013 for microcephaly was eight for every 100,000 live births (before Espin-ZIKV), while in 2021 it was five BPC/E87 for every 100,000 live births (after Espin-ZIKV) (p < 0.01). We observed 689 children with active E60 (from 3 to 8 years of age), in May, 2023. The study showed low social protection for children with suspected CZS. However, of those who benefited from the E60, 98% had active benefits in 2023, demonstrating the important survival of the benefited children. A reduction in the mean number of BPC/E87 grants for microcephaly without specified cause was observed after Espin-ZIKV.
期刊介绍:
Cadernos de Saúde Pública/Reports in Public Health (CSP) is a monthly journal published by the Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation (ENSP/FIOCRUZ).
The journal is devoted to the publication of scientific articles focusing on the production of knowledge in Public Health. CSP also aims to foster critical reflection and debate on current themes related to public policies and factors that impact populations'' living conditions and health care.
All articles submitted to CSP are judiciously evaluated by the Editorial Board, composed of the Editors-in-Chief and Associate Editors, respecting the diversity of approaches, objects, and methods of the different disciplines characterizing the field of Public Health. Originality, relevance, and methodological rigor are the principal characteristics considered in the editorial evaluation. The article evaluation system practiced by CSP consists of two stages.